BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18231621)

  • 1. Selecting patients for immediate cystectomy.
    Shariat SF
    Rev Urol; 2007; 9(4):239-41. PubMed ID: 18231621
    [No Abstract]   [Full Text] [Related]  

  • 2. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
    Sternberg CN; Skoneczna I; Kerst JM; Albers P; Fossa SD; Agerbaek M; Dumez H; de Santis M; Théodore C; Leahy MG; Chester JD; Verbaeys A; Daugaard G; Wood L; Witjes JA; de Wit R; Geoffrois L; Sengelov L; Thalmann G; Charpentier D; Rolland F; Mignot L; Sundar S; Symonds P; Graham J; Joly F; Marreaud S; Collette L; Sylvester R; ; ; ; ;
    Lancet Oncol; 2015 Jan; 16(1):76-86. PubMed ID: 25498218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
    BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer.
    Kulkarni GS; Alibhai SM; Finelli A; Fleshner NE; Jewett MA; Lopushinsky SR; Bayoumi AM
    Cancer; 2009 Dec; 115(23):5450-9. PubMed ID: 19685529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?
    Thalmann GN; Markwalder R; Shahin O; Burkhard FC; Hochreiter WW; Studer UE
    J Urol; 2004 Jul; 172(1):70-5. PubMed ID: 15201740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of high-risk T1G3 bladder cancer: a decision analysis.
    Kulkarni GS; Finelli A; Fleshner NE; Jewett MA; Lopushinsky SR; Alibhai SM
    PLoS Med; 2007 Sep; 4(9):e284. PubMed ID: 17896857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can chemo-radiotherapy plus transurethral tumor resection make cystectomy unnecessary for invasive bladder cancer?
    Shipley WU; Kaufman DS; Heney NM
    Oncology (Williston Park); 1990 Jul; 4(7):25-32; discussion 32-4, 39. PubMed ID: 2143938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer.
    Dalbagni G; Vora K; Kaag M; Cronin A; Bochner B; Donat SM; Herr HW
    Eur Urol; 2009 Dec; 56(6):903-10. PubMed ID: 19632765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
    Lonati C; Baumeister P; Afferi L; Mari A; Minervini A; Krajewski W; Azizi S; Hendricksen K; Martini A; Necchi A; Montorsi F; Briganti A; Colombo R; Tafuri A; Antonelli A; Cerruto MA; Rouprêt M; Masson-Lecomte A; Laukhtina E; D'Andrea D; Shariat SF; Soria F; Marra G; Gontero P; Contieri R; Hurle R; Valiquette AS; Mir MC; Zamboni S; Simeone C; Klatte T; Teoh JY; Yoshida S; Fujii Y; Carando R; Schulz GB; Mordasini L; Mattei A; Moschini M;
    Eur Urol Focus; 2022 Sep; 8(5):1270-1277. PubMed ID: 34419381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a second transurethral resection on the staging of T1 bladder cancer.
    Dalbagni G; Herr HW; Reuter VE
    Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.
    Koie T; Ohyama C; Hashimoto Y; Hatakeyama S; Yamamoto H; Yoneyama T; Kamimura N
    Int J Clin Oncol; 2013 Aug; 18(4):724-30. PubMed ID: 23011100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).
    deVere White RW; Lara PN; Goldman B; Tangen CM; Smith DC; Wood DP; Hussain MH; Crawford ED
    J Urol; 2009 Jun; 181(6):2476-80; discussion 2480-1. PubMed ID: 19371909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.
    Eswara JR; Efstathiou JA; Heney NM; Paly J; Kaufman DS; McDougal WS; McGovern F; Shipley WU
    J Urol; 2012 Feb; 187(2):463-8. PubMed ID: 22177159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate total parenteral nutrition after radical cystectomy and urinary diversion.
    Pham KN; Schwartz LW; Garg T; Langenstroer P; Guralnick ML; See WA; O'Connor RC
    WMJ; 2014 Feb; 113(1):20-3. PubMed ID: 24712216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?
    Spiess PE; Kassouf W; Brown G; Highshaw R; Wang X; Do KA; Kamat AM; Czerniak B; Dinney CP; Grossman HB
    Urology; 2006 Mar; 67(3):466-71. PubMed ID: 16527559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
    Lonati C; Afferi L; Mari A; Minervini A; Krajewski W; Borghesi M; Schulz GB; Rink M; Montorsi F; Briganti A; Colombo R; Martini A; Necchi A; Contieri R; Hurle R; Umari P; Zamboni S; Simeone C; Soria F; Marra G; Gontero P; Teoh JY; Klatte T; Bajeot AS; Roumiguié M; Rouprêt M; Masson-Lecomte A; Laukhtina E; Valiquette AS; Mir MC; Antonelli A; Einerhand SMH; Hendricksen K; Carando R; Fankhauser CD; Baumeister P; Mattei A; Shariat SF; Moschini M;
    World J Urol; 2022 May; 40(5):1167-1174. PubMed ID: 35218372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between short-course high-dose preoperative irradiation with immediate radical cystectomy and salvage cystectomy after full-dose irradiation.
    Nissenkorn I; Baniel J; Slucker D; Servadio C; Winkler H
    Eur Urol; 1990; 18(1):23-6. PubMed ID: 2119307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender Disparity in Cystectomy Postoperative Outcomes: Propensity Score Analysis of the National Surgical Quality Improvement Program Database.
    Bukavina L; Mishra K; Mahran A; Shekar A; Sheyn D; Slopnick E; Hijaz A; Jankowski J; Ponsky L; Nguyen C
    Eur Urol Oncol; 2021 Feb; 4(1):84-92. PubMed ID: 31368436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.